Hosted on MSN21d
FTC says Optum, other prescription benefit managers inflate cancer drug prices 1,000%
The Federal Trade Commission released another investigation Tuesday on pharmacy benefit managers (PBMs), including Minnesota-based Optum. FOX 9 recently found PBMs have been accused of driving ...
Fox 92h
Wisconsin couple sues Optum Rx and Walgreens for son’s asthma death
A Wisconsin couple has filed a lawsuit against Minnesota-based Optum Rx and Walgreens for their son’s asthma-related death ...
Hosted on MSN3d
Generic prescription drug prices marked up as high as 5,000%, investigation finds
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
MedCity News22d
Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings
“Optum is lowering the cost of specialty medications ... Ellen Rudolph, CEO of autoimmune digital health company WellTheory, noted that the FTC’s findings “underscore a critical issue ...
UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report Claims
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
CNN22d
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
“Optum is lowering the cost of specialty medications ... total drug spending between 2017 and 2022. “Also, the FTC buries in footnote 39 its acknowledgement that the interim analysis ...
MinnPost22d
FTC says Minnesota-based Optum, et al., inflate cancer drug prices 1,000%
Joe Augustine and Kelcey Carlson at FOX 9 are reporting Minnesota-based Optum RX, CVS Caremark ... according to an investigation by the Federal Trade Commission. Via WCCO: Public schools in ...
STAT23d
FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system
The latest report accuses the PBMs — CVS Caremark, Optum Rx, and Express Scripts ... according to the FTC. Specifically, the companies were able to generate more than $7.3 billion in revenue ...
USA Today21d
FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers
the U.S. Federal Trade Commission said on Tuesday. From 2017 to 2022, the companies — UnitedHealth Group's UNH.N Optum, CVS Health's CVS.N CVS Caremark and Cigna's CI.N Express Scripts ...
Yahoo Finance22d
FTC releases second report slamming pharmacy benefit managers
Specifically, the FTC’s first report found Caremark, Express Scripts and Optum Rx were prioritizing access to high-cost drugs in return for larger discounts from drugmakers and giving their own ...
AOL22d
FTC alleges PBMs cost consumers $7.3 billion marking up drug prices
But they rebuked the FTC's comments in the accompanying statement, and claimed that their programs instead save, rather than cost, patients money. "Optum is lowering the cost of specialty ...